Rivexia Pharmaceuticals Private Limited
About Rivexia Pharmaceuticals Private Limited
Data last updated:
Rivexia Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 30 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC387532. Its GSTIN is 07AALCR3321F1ZK (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Anuradha Kumari and Amrit Raj.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Ashok Kumar Sehgal F 34/8 Okhla Industrial Area Phase II, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.91 Lakh, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹62,990 (net margin 4%) and EBITDA of ₹85,189 (EBITDA margin 5.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Ashok Kumar Sehgal F 34/8 Okhla Industrial Area Phase II, New Delhi, Delhi, India – 110020
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rivexia Pharmaceuticals Private Limited
The main business activity of Rivexia Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rivexia Pharmaceuticals Private Limited FY 2024 filings available
Rivexia Pharmaceuticals Private Limited reported revenue of ₹15.91 Lakh (up 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Rivexia Pharmaceuticals Private Limited
Revenue rose 12% in the latest year. EBITDA rose 351% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Rivexia Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹85,189 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹62,990 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Rivexia Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 5.4% | •••• | •••• |
| Net Profit Margin | 4% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rivexia Pharmaceuticals are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Rivexia Pharmaceuticals Private Limited
Rivexia Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Swana Pharmaceuticals Private Limited | ₹16 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Gujarat, India |
| Sugam Pharmaceuticals Private Limited | ₹16 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Muktsar, Punjab, India |
| Astrobio Pharmaceuticals Private Limited | ₹15.98 Lakh (FY 2025) | •••• | •••• | 66.0% | •••• | Pune, Maharashtra, India |
| Alegre Pharmaceuticals Private Limited | ₹15.98 Lakh (FY 2025) | •••• | •••• | 63.0% | •••• | Delhi, India |
| Revivewell Pharmaceuticals Private Limited | ₹15.93 Lakh (FY 2025) | •••• | •••• | 232.0% | •••• | Hyderabad, Telangana, India |
| Rivexia Pharmaceuticals Private Limited this company | ₹15.91 Lakh (FY 2024) | •••• | •••• | 12.0% | •••• | New Delhi, Delhi, India |
| Arrios Pharmaceuticals Private Limited | ₹15.9 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | New Delhi, Delhi, India |
| Sitaman Pharmaceuticals Private Limited | ₹15.87 Lakh (FY 2025) | •••• | •••• | -64.0% | •••• | Mumbai, Maharashtra, India |
| D-Nutrocare Pharmaceuticals Private Limited | ₹15.86 Lakh (FY 2025) | •••• | •••• | 63.0% | •••• | Vasai, Maharashtra, India |
| Ziva Pharmaceuticals Private Limited | ₹15.84 Lakh (FY 2020) | •••• | •••• | 35.0% | •••• | Gurgaon, Haryana, India |
| Kingson Pharmaceuticals Private Limited | ₹15.84 Lakh (FY 2025) | •••• | •••• | 50.0% | •••• | Bhopal, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Rivexia Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Rivexia Pharmaceuticals Private Limited
Rivexia Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuradha Kumari Also directs: Efluid Technology Private Limited | Director | 30 Sep 2021 | 5 Years 0 Months | Current |
| Amrit Raj | Additional Director | 01 Aug 2024 | 2 Years 2 Months | Current |
Ownership and Shareholding of Rivexia Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rivexia Pharmaceuticals Private Limited
Rivexia Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rivexia Pharmaceuticals Private Limited
Rivexia Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rivexia Pharmaceuticals Private Limited
Rivexia Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Amrit Raj was appointed as Additional Director on 01 Aug 2024.
Credit Ratings, Litigation & Regulatory Alerts for Rivexia Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rivexia Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rivexia Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rivexia Pharmaceuticals Private Limited
Rivexia Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCR3321F1ZK | Delhi | Active | 13 Apr 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rivexia Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rivexia Pharmaceuticals Private Limited
Rivexia Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 30 September 2021 (5+ years old) and is registered under CIN U24290DL2021PTC387532.
Rivexia Pharmaceuticals reported revenue of ₹15.91 Lakh for FY 2024 (up 12% YoY).
Rivexia Pharmaceuticals has 2 current directors:
- Anuradha Kumari - Director
- Amrit Raj - Additional Director
Rivexia Pharmaceuticals reported a net profit of ₹62,990 (net margin 4%) and EBITDA of ₹85,189 (EBITDA margin 5.4%) for FY 2024, as per its filed financial statements.
The GSTIN of Rivexia Pharmaceuticals is 07AALCR3321F1ZK, registered in Delhi.
The CIN (Corporate Identification Number) of Rivexia Pharmaceuticals is U24290DL2021PTC387532. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rivexia Pharmaceuticals was incorporated on 30 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rivexia Pharmaceuticals by revenue are Swana Pharmaceuticals Private Limited, Sugam Pharmaceuticals Private Limited, Astrobio Pharmaceuticals Private Limited, Alegre Pharmaceuticals Private Limited, Revivewell Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Amrit Raj was appointed as Additional Director on 01 Aug 2024. Rishi Roushan Kant ceased to be Director on 01 Aug 2024. Anuradha Kumari was appointed as Director on 30 Sep 2021.
Yes, Rivexia Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Rivexia Pharmaceuticals is at CO Ashok Kumar Sehgal F 348 Okhla Industrial Area Phase II, New Delhi, Delhi, India – 110020.